How International Standards for Molecular Biomarker Testing in Lung Cancer Have Influenced Which Tests are Routinely PerformedVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. Roy Herbst and David Rimm discuss the 50-gene panel that has become an ISLC-mandated standard for all patients with lung cancer; however, the components of cancer biomarker testing panels must be fluid and respond to new developments in the field as reported in the literature and/or at international cancer meetings, with adoption of the test predicated on standardization and the perceived value of the test.
Matthew Palmgren discusses the benefits of personalized medicines
Dr. Michaelis discusses useful tools in her experience for treatment of polycthemia vera.Supported through funding from Incyte